BCL2L1 and Behcet disease: Studies investigating protein levels of apoptosis-promoting and -inhibiting factors in peripheral blood mononuclear cells have shown that BD patients exhibit significantly reduced levels of anti-apoptotic proteins, such as Bcl-xL, survivin, and Bcl-xL/Bak dimers.